Review decisions
Showing 710 results of 2627 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00286
Issued / Original Publication Date: 2022-08-11
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00985
Product Type: Drug
Control Number: 255983
DIN(s): 02529653, 02529661
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-08-23
Decision / Authorization Date: 2022-08-10
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01043
Product Type: Drug
Control Number: 255153
DIN(s): 02529688
Manufacturer: Tillotts Pharma AG
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-07-27
Decision / Authorization Date: 2022-08-08
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00980
Product Type: Drug
Control Number: 251360
DIN(s): 02529602
Manufacturer: Baxter Corporation
Submission Type: New Drug Submission
Date Filed / Submission Date: 2021-04-13
Decision / Authorization Date: 2022-08-03
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00978
Product Type: Drug
Control Number: 255908
Manufacturer: Janssen Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-08-18
Decision / Authorization Date: 2022-07-29
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD1706623043472
Product Type: Drug
Control Number: 266545
DIN(s): 02539977, 02539985, 02540002, 02540010, 02540029, 02540037, 02540045
Manufacturer: Baxter Corporation
Submission Type: New Drug Submission
Date Filed / Submission Date: 2022-07-29
Issued / Original Publication Date: 2024-01-26
Decision / Authorization Date: 2023-07-27
Updated Date: 2024-12-04
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD1700081467048
Product Type: Drug
Control Number: 266464
DIN(s): 02538539
Manufacturer: AstraZeneca Canada Inc.
Submission Type: New Drug Submission (New Active Substance) - Notice of Compliance with Conditions
Date Filed / Submission Date: 2022-07-29
Issued / Original Publication Date: 2023-11-09
Decision / Authorization Date: 2023-06-16
Updated Date: 2024-11-20
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00977
Product Type: Drug
Control Number: 256188
DIN(s): 02529548, 02529556
Manufacturer: AstraZeneca Canada Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2021-08-28
Decision / Authorization Date: 2022-07-28
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00989
Product Type: Drug
Control Number: 259417
Manufacturer: AstraZeneca Canada Inc.
Submission Type: Supplement to a New Drug Submission - Notice of Compliance with Conditions
Date Filed / Submission Date: 2021-12-09
Decision / Authorization Date: 2022-07-27
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD1695821197450
Product Type: Drug
Control Number: 266471
DIN(s): 02539845, 02539853, 02539861
Manufacturer: Eli Lilly Canada Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2022-07-27
Issued / Original Publication Date: 2023-09-25
Decision / Authorization Date: 2023-07-20
Updated Date: 2024-06-06